St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Body Image in Youth With HIV

Completed

Conditions: Human Immunodeficiency Virus
HIV

Interventions: Other: Questionnaire

First Posted Date: 2012-08-28

Last Posted Date: 2014-04-14

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 146

Registration Number: NCT01673750

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy

Not Applicable

Completed

Conditions: Malignant Peripheral Nerve Sheath Sarcoma
Chondrosarcoma of the Bone
Osteosarcoma
Ewing's Sarcoma
Synovial Sarcoma
Rhabdomyosarcoma
Malignant Fibrous Histiocytoma of the Bone

Interventions: Other: Endurance
Other: Strengthening
Other: Stretching
Other: Home exercise program

First Posted Date: 2012-08-28

Last Posted Date: 2015-12-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 20

Registration Number: NCT01674101

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting

Completed

Conditions: Smoking
Cancer
Sickle Cell Disease

Interventions: Other: Questionnaire

First Posted Date: 2012-08-27

Last Posted Date: 2015-03-05

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 88

Registration Number: NCT01673243

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)

Phase 1

Completed

Conditions: Diffuse Intrinsic Pontine Glioma
High-grade Glioma

Interventions: Drug: Crizotinib
Drug: Dasatinib

First Posted Date: 2012-07-19

Last Posted Date: 2019-03-22

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 36

Registration Number: NCT01644773

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Phase 1

Completed

Conditions: Lymphoma
Renal Cell Carcinoma
Gastrointestinal Tumor
Hepatic Tumor
Wilms Tumor
Clear Cell Carcinoma
Melanoma
Neuroblastoma
Rhabdomyosarcoma
Ewing Sarcoma

Interventions: Drug: alemtuzumab
Drug: fludarabine
Drug: sirolimus
Drug: Busulfan
Drug: melphalan
Biological: stem cells
Device: CliniMACS

First Posted Date: 2012-06-21

Last Posted Date: 2020-10-19

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 23

Registration Number: NCT01625351

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Phase 2

Terminated

Conditions: Acute Lymphoblastic Leukemia
Chronic Myelocytic Leukemia
Juvenile Myelomonocytic Leukemia
Hodgkin or Non-Hodgkin Lymphoma
Sarcoma, Myeloid
Myelodysplastic Syndrome
Acute Myelocytic Leukemia

Interventions: Drug: clofarabine
Drug: cytarabine
Drug: busulfan
Drug: Plerixafor
Drug: cyclophosphamide
Drug: antithymocyte globulin (rabbit)
Biological: stem cells
Drug: Tacrolimus
Drug: mycophenolate mofetil

First Posted Date: 2012-06-18

Last Posted Date: 2017-02-20

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 34

Registration Number: NCT01621477

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)

Completed

Conditions: Healthy

First Posted Date: 2012-05-03

Last Posted Date: 2015-01-13

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 426

Registration Number: NCT01591213

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease

Completed

Conditions: Cancer
Sickle Cell Disease

Interventions: Other: Text messaging
Other: Questionnaire
Other: Interviews

First Posted Date: 2012-05-03

Last Posted Date: 2015-03-05

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 77

Registration Number: NCT01591187

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Phase 1

Completed

Conditions: Neuroblastoma

Interventions: Biological: Humanized anti-GD2 antibody
Drug: Chemotherapy
Other: Cytokines
Biological: Natural killer cells
Device: CliniMACS

First Posted Date: 2012-04-12

Last Posted Date: 2018-11-15

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 34

Registration Number: NCT01576692

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Massive Iron Deposit Assessment

Not Applicable

Completed

Conditions: Excessive Body Iron Burden
Iron Overload

Interventions: Device: R2*-UTE
Device: R2*-GRE
Procedure: Liver biopsy

First Posted Date: 2012-04-06

Last Posted Date: 2019-06-11

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 142

Registration Number: NCT01572922

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy